Where are the new drugs?

images
Pharmaceutical companies have been concentrating efforts on replacing blockbusters with new and improved versions or trying to get a slice of lucrative markets such as the cholesterol market. Still, one has to wonder where the new "class" of drugs are to treat an aging population? For example we are now a nation that is so overweight that it may strain our health system like never before.



You would think that pharma could have foreseen that an aging baby boomer population would begin to put on weight as age kicks in and metabolisms decrease. The only drug that has received any attention is one that can cause loose stools and gas. Meridia is a controlled drug and although there are rumors of drugs in development unless one is approved within the next 5 years it might be too late. By then more and more people will get diabetes, be treated for high cholesterol and high blood pressure and probably need knee and hip replacements because the stress on the body from carrying the extra weight will necessitate it.



screenshot_01
Obesity in the US 2006 by state





Of course pharma is not to blame for an obese population, that is due to aging, huge portion sizes and lack of exercise, but can you imagine the potential sales of a weight loss drug that could curb appetite and help us burn fat with a minimum of side effects? Sales of such a product could make Lipitors $12 billion sales look like a small dot on the radar screen.


The development of such a drug is indicative of just how hard it is to develop new medications and bring them to market. Cancer death rates are declining because of early detection not new blockbusters that fight the disease. Most cancer drugs only prolong life they don't "cure the patient". It will probably take a small biotech firm funded by venture capitol dollars to develop a potential new drug for weight loss. Even in early development the chances of making it through to approval are less than 30%. One has to ask though is it the "development process" that is causing these issues or is pharma running out of people who could possibly create these products. The biggest complaint I here from people in R&D is that the bureaucracy of working in big companies leads to more paperwork and less time to work on things that they really enjoy such as asking "what if..."


Do we really need a new statin, a new blood thinner, a new antidepressant medication or is this just the safest path to follow to ensure that the people on the Street are happy. Ask yourself this questions though..."when was the last time the introduction of a new drug made national headlines?". The only one I can remember was Gleevec but it seems like that was a long long time ago.

|